Publications




Kuehlbach et al. (2021) Recapitulating the Angiogenic Switch in a Hydrogel-Based 3D In Vitro Tumor-Stroma Model. Bioengineering 8: 186 (Article)

An organotypic in vitro model containing microtumor spheroids, macrophages, neutrophils, fibroblasts and endothelial cells, allowing for the analysis of tumor–stroma interactions, was established with 3-D Life Hydrogel. After 20 days of culture, spheroid growth, a fibroblast network and vascular sprouting was clearly visible, the latter likely to be induced by endogenous VEGF. Cultures were miniaturized on transwell 96-well plates and treated with the drug cisplatin showing a reduction of tumor spheroid size and the fibroblast network. Results suggest that the model is highly suitable as a testing platform for novel anticancer therapeutics targeting the tumor as well as the vascular compartment.

Applications
Drug screening, tumor-stroma model, cell-based therapeutic development, drug testing, cancer research

Methods
Fluorescence microscopy, drug screening, phase-contrast microscopy, culture in multiwell inserts

Cells
H838 (human non-small-cell lung carcinoma), HCT 116 (colon carcinoma, human), HUVECs (Human Umbilical Vein Endothelial Cells), HL-60 (human, differentiated to neutrophils), U937 (human lymphoblast), Human dermal fibroblasts

Products used
3-D Life RGD Peptide
3-D Life Dextran-CD Hydrogel SG

Follow us
Company
  • Contact Us
keyboard_arrow_up
We use cookies on our website. They are essential for the operation of the site. We do not track personal information.